Literature DB >> 9128773

Pathogenetic relevance of the pregnancy hormone relaxin to inborn hip instability.

J Forst1, C Forst, R Forst, K D Heller.   

Abstract

The etiology of inborn hip dysplasia is unknown. In general, a multifactorial genesis is assumed. The influence of hormones on the development of the fetal hip joint and its stability is discussed as well as mechanical influences. This study was carried out with the intention to examine the correlation between the concentration of the pregnancy hormone relaxin and the stability of the hip joint in newborns. Both hips of 90 newborn children were examined clinically and sonographically. In 25 hips (13.9%), pathological sonograms according to the classification of Graf were found. The relaxin concentration was measured in cord blood using a heterologous radioimmunoassay. Statistical evaluation revealed an insignificant decrease of relaxin concentration with increasing sonographic hip instability. The results indicate that hip instability frequently occurs with decreasing relaxin concentration. These facts contradict the earlier assumption that hip instability coincides with increased relaxin concentrations in newborns. We assume that there is a worse preparation of the pelvis and the birth canal during pregnancy due to the lower relaxin concentration and thus that there could be a higher pressure on the fetus in the perinatal phase. A decreased relaxin concentration seems to have no direct effect on the hip joint tissue, but indirectly there is consequent rigidity of the tissue in mother and child, which can further promote the development of hip instability.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9128773     DOI: 10.1007/bf00393711

Source DB:  PubMed          Journal:  Arch Orthop Trauma Surg        ISSN: 0936-8051            Impact factor:   3.067


  12 in total

1.  Hip dysplasia and the performing arts: is there a correlation?

Authors:  Robert Turner; Eilish O'Sullivan; Jaime Edelstein
Journal:  Curr Rev Musculoskelet Med       Date:  2012-03

2.  A review of environmental factors implicated in human developmental dysplasia of the hip.

Authors:  Amanda M L Rhodes; Nicholas M P Clarke
Journal:  J Child Orthop       Date:  2014-10-25       Impact factor: 1.548

3.  Bilateral Staged Total Hip Replacement and the Natural Progress of an Untreated Case of Developmental Dysplasia (Dislocation) of the Hip: A Clinical Case Report by the Surgeon and the Patient.

Authors:  Hamid Honarpisheh; Mohammad Taghi Ghazavi
Journal:  Iran J Med Sci       Date:  2015-07

4.  Seasonal variation in children with developmental dysplasia of the hip.

Authors:  Randall T Loder; Cody Shafer
Journal:  J Child Orthop       Date:  2014-02-06       Impact factor: 1.548

5.  Seasonal variation in adult hip disease secondary to osteoarthritis and developmental dysplasia of the hip.

Authors:  Tatsuya Sueyoshi; Merrill A Ritter; Kenneth E Davis; Randall T Loder
Journal:  World J Orthop       Date:  2016-12-18

Review 6.  Developmental dysplasia of the hip: update of management.

Authors:  Alfonso Vaquero-Picado; Gaspar González-Morán; Enrique Gil Garay; Luis Moraleda
Journal:  EFORT Open Rev       Date:  2019-09-17

7.  DNA hypermethylation of GDF5 in developmental dysplasia of the hip (DDH).

Authors:  Taghi Baghdadi; Mohammad Nejadhosseinian; Reza Shirkoohi; Reza Mostafavi Tabatabaee; Seyed S Tamehri; Mojtaba Saffari; S M Javad Mortazavi
Journal:  Mol Genet Genomic Med       Date:  2019-07-23       Impact factor: 2.183

8.  Testosterone reduces knee passive range of motion and expression of relaxin receptor isoforms via 5α-dihydrotestosterone and androgen receptor binding.

Authors:  Firouzeh Dehghan; Sekaran Muniandy; Ashril Yusof; Naguib Salleh
Journal:  Int J Mol Sci       Date:  2014-03-17       Impact factor: 5.923

Review 9.  The epidemiology and demographics of hip dysplasia.

Authors:  Randall T Loder; Elaine N Skopelja
Journal:  ISRN Orthop       Date:  2011-10-10

Review 10.  The effect of relaxin on the musculoskeletal system.

Authors:  F Dehghan; B S Haerian; S Muniandy; A Yusof; J L Dragoo; N Salleh
Journal:  Scand J Med Sci Sports       Date:  2013-11-28       Impact factor: 4.221

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.